Publications by authors named "Martha D Gay"

Claim this Profile
I
Implicating the cholecystokinin B receptor in liver stem cell oncogenesis.
Martha D Gay, Jack C Drda, Wenqiang Chen, Yimeng Huang, Amal A Yassin

Am J Physiol Gastrointest Liver Physiol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma.
Narayan Shivapurkar, Martha D Gay, Aiwu Ruth He, Wenqiang Chen, Shermineh Golnazar

Int J Mol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non-alcoholic Steatohepatitis.
Atoosa Rabiee, Martha D Gay, Narayan Shivapurkar, Hong Cao, Sandeep Nadella

Clin Pharmacol Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Educational initiative in an NCATS TL1 training program to address the impact of systemic racism on human health, biomedical research, and the translational scientist.
Martha D Gay, Kimberly A Bell, Emily A Bujold, Marilla Geraci, Dexter L Lee

J Clin Transl Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Chronic Use of High Dose Proton Pump Inhibitors Increase Risk for Pancreatic Cancer?
Matthew A Huber, Sandeep Nadella, Hong Cao, Bhaskar Kallakury, Robin D Tucker, Martha D Gay

Pancreas· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetic Assessment of Oral Proglumide in Those with Hepatic Impairment.
Christine C Hsu, Sunil Bansal, Hong Cao, Coleman I Smith, Aiwu Ruth He, Martha D Gay

Pharmaceutics· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome.
Martha D Gay, Hong Cao, Narayan Shivapurkar, Sivanesan Dakshanamurthy, Bhaskar Kallakury

Int J Mol Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment.
Zoe X Malchiodi, Hong Cao, Martha D Gay, Anita Safronenka, Sunil Bansal

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular Cancer.
Martha D Gay, Anita Safronenka, Hong Cao, Felice H Liu, Zoe X Malchiodi

Cancer Prev Res (Phila)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.
Robin D Tucker, Victor Ciofoaia, Sandeep Nadella, Martha D Gay, Hong Cao

Dig Dis Sci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases.
Nicholas Osborne, Rebecca Sundseth, Martha D Gay, Hong Cao, Robin D Tucker

Am J Physiol Gastrointest Liver Physiol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis